Personalis, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Personalis, Inc. (PSNL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $5.35 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-08-04
- Personalis, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2026-06-30 was $5.35, a 54.18% increase year-over-year.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2026-03-31 was $5.29, a 99.62% increase year-over-year.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-09-30 was $4.47, a 25.92% increase year-over-year.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-06-30 was $3.47, a 277.17% increase year-over-year.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $3.20, a 109.15% increase from fiscal 2024.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $1.53, a 15.47% decline from fiscal 2023.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $1.81, a 43.61% decline from fiscal 2022.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $3.21, a 75.57% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.35 10-Q · filed 2026-08-04 | $5.30 10-Q · filed 2026-08-04 | ||
| 2026-03-31 | $5.29 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $3.20 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $4.47 10-Q · filed 2025-11-04 | $3.01 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | $3.47 10-Q · filed 2026-08-04 | $2.74 10-Q · filed 2026-08-04 | ||
| 2025-03-31 | $2.65 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | $1.53 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $3.55 10-Q · filed 2025-11-04 | $1.49 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | $0.92 10-Q · filed 2025-08-05 | $1.05 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | $1.61 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $1.81 10-K · filed 2025-02-27 | |||
| 2023-09-30 | $1.33 10-Q · filed 2024-11-06 | $1.82 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | $1.51 10-Q · filed 2024-08-07 | $1.84 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | $1.91 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | $3.21 10-K · filed 2024-02-28 | |||
| 2022-09-30 | $3.50 10-Q · filed 2023-11-07 | $3.60 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | $3.19 10-Q · filed 2023-08-08 | $3.99 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $6.59 10-Q · filed 2023-05-03 | |||
| 2021-12-31 | $13.14 10-K · filed 2024-02-28 | |||
| 2021-09-30 | $12.53 10-Q · filed 2022-11-02 | $13.32 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | $12.34 10-Q · filed 2022-08-03 | $13.55 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | $28.21 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $7.17 10-K · filed 2023-02-23 | |||
| 2020-09-30 | $11.71 10-Q · filed 2021-11-04 | $5.40 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $6.70 10-Q · filed 2021-08-04 | $4.81 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | $3.46 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | $8.00 10-K · filed 2022-02-24 | |||
| 2019-09-30 | $8.81 10-Q · filed 2020-11-05 | $8.19 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $8.40 10-Q · filed 2020-08-06 | $8.07 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $7.76 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $5.68 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $4.44 10-Q · filed 2019-11-13 | $3.44 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $3.37 10-Q · filed 2019-08-13 | $3.37 10-Q · filed 2019-08-13 | ||
| 2017-12-31 | $2.44 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |